DESIGNATION STATEMENT InforMed designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Substance Use Disorders: A DEA Requirement 8 COURSE SATISFIES
FACULTY Brad Bendesky, MD FACEP, FAAEM Chair, Department of Emergency Medicine Mercy Catholic Medical Center-Mercy Fitzgerald Hospital Associate Professor of Clinical Emergency Medicine Drexel College of Medicine, Philadelphia PA Humberto Reinoso, PhD, FNP-BC, ENP-BC Assistant Professor Nurse Practitioner Coordinator Georgia Baptist College of Nursing of Mercer University Robyn B. Caldwell DNP, FNP-BC, PMHNP Medical Writer
This course satisfies eight (8) hours on the DEA’s new one-time MATE requirement.
Effective June 27, 2023, renewing DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or substance use disorders.
ACTIVITY PLANNER Michael Brooks CME Director InforMed DISCLOSURE OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, InforMed implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity. FACULTY/PLANNING COMMITTEE DISCLOSURE The following faculty and/or planning committee members have indicated they have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: • Brad Bendesky, MD • Humberto Reinoso, PhD, FNP-BC, ENP-BC • Robyn B. Caldwell DNP, FNP-BC, PMHNP STAFF AND CONTENT REVIEWERS InforMed staff, input committee and all content validation reviewers involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. DISCLAIMER *2023. All rights reserved. These materials, except those in the public domain, may not be reproduced without permission from InforMed. This publication is designed to provide general information prepared by professionals in regard to the subject matter covered. It is provided with the understanding that InforMed, Inc is not engaged in rendering legal, medical or other professional services. Although prepared by professionals, this publication should not be utilized as a substitute for professional services in specific situations. If legal advice, medical advice or other expert assistance is required, the service of a professional should be sought.
22
Powered by FlippingBook